Medico Remedies Limited has informed the Exchange about Action(s) taken or orders passed
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medico Remedies Limited received a Standard Operating Procedure (SoP) notice from both NSE and BSE on 20th February 2026 for alleged non-compliance of Regulation 6(1) of SEBI Listing Regulations, which deals with the appointment of a Compliance Officer. Each exchange has levied a penalty of Rs. 63,720 (inclusive of GST) on the company. In response, the company filed a Waiver Application with both NSE and BSE on 24th February 2026, seeking to get the fine waived. The company has confirmed there is no material impact on its financials, operations, or other activities due to this matter.
This is a minor compliance penalty worth only Rs. 63,720 from each exchange, which is negligible compared to typical company operations. With a waiver already filed, the stock price is unlikely to be meaningfully affected.